Younger breast cancer patients may feel more pain from standard supportive drug

NCT ID NCT04174742

Recruiting now Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 19 times

Summary

This study compares pain levels in younger (45 and under) versus older women receiving pegfilgrastim, a drug that helps boost white blood cells during chemotherapy for non-metastatic breast cancer. Researchers want to see if younger women report more frequent or intense pain. The study does not change or interfere with cancer treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Wake Forest Baptist Comprehensive Cancer Center
RECRUITING

Winston-Salem, North Carolina, 27157, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

BREAST BREAST CANCER